Oregon-developed biological warfare drug treatment nears FDA finish line

Siga Technologies Inc.'s research and development operation in Corvallis for 15 years has been developing an antiviral drug that targets smallpox

Source: bizjournals.com Health Care:Physician Practices headlines - March 1, 2018 Category: American Health Authors: Elizabeth Hayes Source Type: news